FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to chemical-pharmaceutical industry and medicine and concerns a new sustained release cilostasol pharmaceutical composition for preventing intermittent claudication and secondary strokes.
EFFECT: sustained release cilostasol tablets are disclosed.
6 cl, 5 ex, 5 tbl
Authors
Dates
2019-04-24—Published
2018-05-11—Filed